JOHN FOREYT to Blood Pressure
This is a "connection" page, showing publications JOHN FOREYT has written about Blood Pressure.
Connection Strength
0.674
-
Impact of weight loss on ankle-brachial index and interartery blood pressures. Obesity (Silver Spring). 2014 Apr; 22(4):1032-41.
Score: 0.152
-
Mentored implementation to initiate a diabetes program in an underserved community: a pilot study. BMJ Open Diabetes Res Care. 2021 08; 9(1).
Score: 0.127
-
Blood pressure and symptoms of depression and anxiety: a prospective study. Am J Hypertens. 2001 Jul; 14(7 Pt 1):660-4.
Score: 0.126
-
Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trial. Nutr J. 2010 Feb 23; 9:8.
Score: 0.058
-
Weight loss with meal replacement and meal replacement plus snacks: a randomized trial. Int J Obes (Lond). 2005 Sep; 29(9):1107-14.
Score: 0.042
-
Implications of Look AHEAD for clinical trials and clinical practice. Diabetes Obes Metab. 2014 Dec; 16(12):1183-91.
Score: 0.039
-
The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med. 2013 Mar; 126(3):236-42, 242.e1-2.
Score: 0.035
-
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010 Sep 27; 170(17):1566-75.
Score: 0.030
-
A classification system to evaluate weight maintainers, gainers, and losers. J Am Diet Assoc. 1997 May; 97(5):481-8.
Score: 0.024
-
Physical activity assessed with three different methods and the Framingham Risk Score on 10-year coronary heart disease risk. Med Sci Monit. 2008 Jan; 14(1):CR1-9.
Score: 0.012
-
Soup consumption as a behavioral weight loss strategy. J Am Diet Assoc. 1986 Apr; 86(4):524-6.
Score: 0.011
-
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes Care. 2002 Jul; 25(7):1123-8.
Score: 0.008
-
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999 Jan 20; 281(3):235-42.
Score: 0.007
-
Nonpharmacologic approaches to the treatment of hypertension. Circulation. 1987 Jul; 76(1 Pt 2):I104-9.
Score: 0.003